536
Views
8
CrossRef citations to date
0
Altmetric
Clinical Research

Prepacked naloxone administration for suspected opioid overdose in the era of illicitly manufactured fentanyl: a retrospective study of regional poison center data

, ORCID Icon, , , & ORCID Icon
Pages 117-123 | Received 21 Jan 2019, Accepted 26 Apr 2019, Published online: 16 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ola Dale. (2022) Pharmacokinetic considerations for community-based dosing of nasal naloxone in opioid overdose in adults. Expert Opinion on Drug Metabolism & Toxicology 18:3, pages 203-217.
Read now

Articles from other publishers (7)

Eamonn Kelly, Katy Sutcliffe, Damiana Cavallo, Nokomis Ramos‐Gonzalez, Norah Alhosan & Graeme Henderson. (2021) The anomalous pharmacology of fentanyl. British Journal of Pharmacology 180:7, pages 797-812.
Crossref
Brian Gooley, Benjamin Weston, Mario Riccardo Colella & Andrew Farkas. (2022) Outcomes of law enforcement officer administered naloxone. The American Journal of Emergency Medicine 62, pages 25-29.
Crossref
Stevie C. Britch & Sharon L. Walsh. (2022) Treatment of opioid overdose: current approaches and recent advances. Psychopharmacology 239:7, pages 2063-2081.
Crossref
Arne Kristian Skulberg, Ida Tylleskär, Morten Valberg, Anne‐Cathrine Braarud, Jostein Dale, Fridtjof Heyerdahl, Tore Skålhegg, Jan Barstein, Sindre Mellesmo & Ola Dale. (2022) Comparison of intranasal and intramuscular naloxone in opioid overdoses managed by ambulance staff: a double‐dummy, randomised, controlled trial. Addiction 117:6, pages 1658-1667.
Crossref
Phil Skolnick. (2022) Treatment of overdose in the synthetic opioid era. Pharmacology & Therapeutics 233, pages 108019.
Crossref
Carolyn A. Chan, Bethany Canver, Ryan McNeil & Kimberly L. Sue. (2022) Harm Reduction in Health Care Settings. Medical Clinics of North America 106:1, pages 201-217.
Crossref
Jaya Amaram-Davila, Tarun Mallipeddi & Akhila Reddy. (2020) Opioid Prescribing with Take-Home Naloxone: Rationale and Recommendations. Current Anesthesiology Reports 10:4, pages 428-435.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.